ethyl 3-(naphthalen-1-yl)-2-nitroacrylate | 60859-82-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: ethyl 3-(naphthalen-1-yl)-2-nitroacrylate
• 英文别名: ethyl (Z)-3-(naphthalen-1-yl)-2-nitroacrylate；3-Naphthalen-1-yl-2-nitro-acrylic acid ethyl ester；ethyl (Z)-3-naphthalen-1-yl-2-nitroprop-2-enoate
• CAS: 60859-82-7
• 化学式: C₁₅H₁₃NO₄
• 分子量: 271.273
• InChiKey: OEYQTLOPFACQGV-UVTDQMKNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  72.1
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  硝基乙酸乙酯 、 [1]naphthylmethylen-aniline 在 乙酸酐 作用下， 反应 8.0h， 以53.846%的产率得到
  参考文献：
  名称：

  3,4,5-三取代异恶唑啉N-氧化物的催化对映选择性合成和3,4,5-三取代异恶唑的区域选择性合成

  摘要：

  已开发出方便的3,4,5-三取代的异恶唑啉N-氧化物的催化不对称合成和3,4,5-三取代的异恶唑的区域选择性合成。

  DOI：

  10.1002/ejoc.201801693

文献信息

• Arylmethylene substituted N-acyl-beta-amino alcohols
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP2018859A1

  公开（公告）日：2009-01-28

  The present invention relates to arylmethylene substituted N-Acyl-β-amino alcohols of the formula I in which Y is selected from the aryl or heteroaryl groups: and R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及式I的芳基亚甲基取代的N-酰基-β-氨基醇 其中 Y 从芳基或杂芳基中选择: 和 R1、R2、R3、R4、R5、Q、X和W的含义如描述中所定义。 根据本发明的化合物是有效的FSH拮抗剂，例如可用于男性或女性的生育控制，或用于骨质疏松症的预防和/或治疗。
• Domino reactions for the synthesis of various α-substituted nitro alkenes
  作者：Stefania Fioravanti、Lucio Pellacani、Maria Cecilia Vergari

  DOI：10.1039/c1ob06260c

  日期：——

  Efficient one-pot methods for the synthesis of variously functionalised conjugated nitro alkenes have been reported. Despite the utility in different fields of these compounds, only a few multi-step syntheses have been reported in the literature, giving the target compounds in low overall yields. α-Nitro acrylates or cinnamates, α-nitro α,β-unsaturated ketones and, most importantly, aromatic and heteroaromatic

  已经报道了用于合成各种官能化的共轭硝基烯烃的有效的一锅法。尽管这些化合物在不同领域有实用性，但文献中仅报道了几步合成，以较低的总收率得到了目标化合物。以高收率获得了α-硝基丙烯酸酯或肉桂酸酯，α-硝基α，β-不饱和酮，以及最重要的是芳香族和杂芳香族（E）-2-硝基烯丙醇，这些化合物具有众所周知的抗癌活性。通过多米诺骨牌缩合脱水过程获得高非对映异构体纯度。
• Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols
  申请人：WORTMANN Lars

  公开号：US20090082372A1

  公开（公告）日：2009-03-26

  The present invention relates to arylmethylene substituted N-Acyl-β-amino alcohols of the formula I in which Y is selected from the aryl or heteroaryl groups: and R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及公式I的芳基亚甲基取代的N-酰基-β-氨基醇化合物，其中Y选自芳基或杂芳基基团：R1，R2，R3，R4，R5，Q，X和W的含义如描述中所定义。本发明的化合物是有效的FSH拮抗剂，例如可用于男性或女性的生育控制，或用于骨质疏松症的预防和/或治疗。
• [EN] ARYLMETHYLENE SUBSTITUTED N-ACYL-ß-AMINO ALCOHOLS<br/>[FR] N-ACYL-?-AMINO ALCOOLS À SUBSTITUTION ARYLMÉTHYLÈNE
  申请人：BAYER SCHERING PHARMA AG

  公开号：WO2009013354A1

  公开（公告）日：2009-01-29

  The present invention relates to arylmethylene substituted N-Acyl-β-amino alcohols of the formula (I) : in which Y is selected from the aryl or heteroaryl groups: formula (II); and R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.
• Catalytic Enantioselective Synthesis of 3,4,5-Trisubstituted Isoxazoline <i>N</i> -Oxides and Regioselective Synthesis of 3,4,5-Trisubstituted Isoxazoles
  作者：Subas Chandra Sahoo、Subhas Chandra Pan

  DOI：10.1002/ejoc.201801693

  日期：2019.2.14

  A convenient catalytic asymmetric synthesis of 3,4,5‐trisubstituted isoxazoline N‐oxides and regioselective synthesis of 3,4,5‐trisubstituted isoxazoles has been developed.

  已开发出方便的3,4,5-三取代的异恶唑啉N-氧化物的催化不对称合成和3,4,5-三取代的异恶唑的区域选择性合成。